prof. dr. Ruth De Bruyne

Journal Article
A1
open access

Concomitant treatment with lumasiran and nedosiran in a child with primary hyperoxaluria type 1

Eline Braekman, Ann Raes (UGent) , Ruth De Bruyne (UGent) , PATRICK VERLOO (UGent) and Agnieszka Prytula-Ebels (UGent)

(2025) KIDNEY INTERNATIONAL REPORTS. 10(2). p.620-621

Add to list

Journal Article
A2
open access

Neonatal cholestasis progressing to a multisystem syndrome with liver cirrhosis in two siblings with FARSA deficiency : an evolving hepatological phenotype

Yoni Aelvoet (UGent) , PATRICK VERLOO (UGent) , Arnaud Vanlander (UGent) , Saskia Vande Velde (UGent) , Stephanie Van Biervliet (UGent) , Pauline De Bruyne (UGent) , Levi Hoste (UGent) , Annelies Dheedene (UGent) , Lore Pottie (UGent) , Anne Hoorens (UGent) , et al.

(2025) JIMD REPORTS. 66(3).

Add to list

Journal Article
A1
open access

Pediatric to adult care transfer in rare liver diseases : recommendations based on insights from a European omnistakeholder event

Karsten Vanden Wyngaert (UGent) , Janne Suykens (UGent) , Deirdre Kelly, Isabel Goncalves, Ena Lindhart Thomsen, Jose Willemse, Zoe Marino, Joao Madaleno, Jemma Day, Marianne Samyn, et al.

(2025) JHEP REPORTS.

Add to list

Conference Paper

Cardiopulmonary exercise testing in youth living with overweight or obesity: a single-center experience

Maarten Buytaert (UGent) , Ilse Coomans (UGent) , Sander Lefere (UGent) , Ruth De Bruyne (UGent) and Kristof Vandekerckhove (UGent)

(2025)

Add to list

The impact of cardiopulmonary fitness on metabolic dysfunction-associated steatotic liver disease in a combined lifestyle intervention for adolescents with obesity

Maarten Buytaert (UGent) , Ilse Coomans (UGent) , Ellen Dupont, Kristof Vandekerckhove (UGent) , Sander Lefere (UGent) and Ruth De Bruyne (UGent)

(2025) 37th Belgian Week of Gastro Enterology, Abstracts.

Add to list

The impact of cardiopulmonary fitness on metabolic dysfunction-associated steatotic liver disease in a combined lifestyle intervention for adolescents with obesity

Maarten Buytaert (UGent) , Ilse Coomans (UGent) , Ellen Dupont, Kristof Vandekerckhove (UGent) , Sander Lefere (UGent) and Ruth De Bruyne (UGent)

(2025) Winter Symposium Obesity 2025, Abstracts.

Add to list

The impact of cardiopulmonary fitness on steatotic liver disease in a combined lifestyle intervention for adolescents with obesity

Maarten Buytaert (UGent) , Ilse Coomans (UGent) , Ellen Dupont, Kristof Vandekerckhove (UGent) , Ruth De Bruyne (UGent) and Sander Lefere (UGent)

(2025) EASL SLD Summit 2025 Abstract Book. p.111-111

Add to list

Journal Article
A1
open access

The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature

Anneleen Heldens (UGent) , Christophe Casteleyn (UGent) , Louis Onghena (UGent) , Milton Boaheng Antwi (UGent) , Sara Neyt (UGent) , Benedicte Descamps (UGent) , Christian Vanhove (UGent) , Xavier Verhelst (UGent) , Sarah Raevens (UGent) , Hans Van Vlierberghe (UGent) , et al.

(2025) BIOMEDICINE & PHARMACOTHERAPY. 183.

Add to list

Journal Article
A2
open access

A matrix tool to foster patient engagement in children, adolescents and young adults: report from a multistakeholder workshop

Maria Cavaller Bellaubi (UGent) , Eva Degraeuwe (UGent) , Johan Vande Walle (UGent) , Elke Gasthuys (UGent) , Agnieszka Prytula-Ebels (UGent) , [missing] the expert group, Karel Allegaert, Arianna Bertolani, Donato Bonifazi, Katia Boven, et al.

(2024) RESEARCH INVOLVEMENT AND ENGAGEMENT. 10(1).

Add to list

Transgenerational maternal obesity induces mitochondrial dysfunction and aggravates MASLD, which can be reversed by metabolic drug candidates

Anneleen Heldens (UGent) , Milton Boaheng Antwi (UGent) , Louis Onghena (UGent) , Lindsey Devisscher (UGent) , Xavier Verhelst (UGent) , Sarah Raevens (UGent) , Hans Van Vlierberghe (UGent) , Ruth De Bruyne (UGent) , Anja Geerts (UGent) and Sander Lefere (UGent)

(2024) JOURNAL OF HEPATOLOGY. In Journal of Hepatology 80(Supplement 1). p.S57-S57

Academic Bibliography

prof. dr. Ruth De Bruyne

Concomitant treatment with lumasiran and nedosiran in a child with primary hyperoxaluria type 1

Neonatal cholestasis progressing to a multisystem syndrome with liver cirrhosis in two siblings with FARSA deficiency : an evolving hepatological phenotype

Pediatric to adult care transfer in rare liver diseases : recommendations based on insights from a European omnistakeholder event

Cardiopulmonary exercise testing in youth living with overweight or obesity: a single-center experience

The impact of cardiopulmonary fitness on metabolic dysfunction-associated steatotic liver disease in a combined lifestyle intervention for adolescents with obesity

The impact of cardiopulmonary fitness on metabolic dysfunction-associated steatotic liver disease in a combined lifestyle intervention for adolescents with obesity

The impact of cardiopulmonary fitness on steatotic liver disease in a combined lifestyle intervention for adolescents with obesity

The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature

A matrix tool to foster patient engagement in children, adolescents and young adults: report from a multistakeholder workshop

Transgenerational maternal obesity induces mitochondrial dysfunction and aggravates MASLD, which can be reversed by metabolic drug candidates

Contents

Support

Contact